Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23
Sophie Garnier, Magdaléna Harakaľová, Stefan Weiß, et al.
European Heart Journal (2021) Vol. 42, Iss. 20, pp. 2000-2011
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

2023 ESC Guidelines for the management of cardiomyopathies
Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3503-3626
Open Access | Times Cited: 988
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Arthur A.M. Wilde, Christopher Semsarian, Manlio F. Márquez, et al.
EP Europace (2022) Vol. 24, Iss. 8, pp. 1307-1367
Open Access | Times Cited: 251
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
Arthur A.M. Wilde, Christopher Semsarian, Manlio F. Márquez, et al.
Heart Rhythm (2022) Vol. 19, Iss. 7, pp. e1-e60
Open Access | Times Cited: 157
Insights on Human Small Heat Shock Proteins and Their Alterations in Diseases
B. Tedesco, Riccardo Cristofani, Veronica Ferrari, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 52
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Arthur A.M. Wilde, Christopher Semsarian, Manlio F. Márquez, et al.
Journal of Arrhythmia (2022) Vol. 38, Iss. 4, pp. 491-553
Open Access | Times Cited: 40
From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
Lia Crotti, Pedro Brugada, Hugh Calkins, et al.
EP Europace (2023) Vol. 25, Iss. 8
Open Access | Times Cited: 22
Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID
Kaiming Wang, Mobin Khoramjoo, Karthik K. Srinivasan, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101254-101254
Open Access | Times Cited: 22
Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review
Jobanjit Phulka, Mishal Ashraf, Beenu K. Bajwa, et al.
Circulation Genomic and Precision Medicine (2023) Vol. 16, Iss. 3, pp. 286-313
Closed Access | Times Cited: 17
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
Rudolf A. de Boer, Stéphane Heymans, Johannes Backs, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 406-420
Open Access | Times Cited: 38
Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy
Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7339-7339
Open Access | Times Cited: 4
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine
Marta Gigli, Davide Stolfo, Marco Merlo, et al.
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 4
Effect of high glucose on the gene expression profiling in cardiac fibroblasts from rats at different ages
Quqian Mo, Angyu Zhan, Rixing Bai, et al.
PeerJ (2025) Vol. 13, pp. e19040-e19040
Open Access
Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes
Albert Henry, Xiaodong Mo, Chris Finan, et al.
Nature Genetics (2025)
Open Access
Epigenome-wide association study for dilated cardiomyopathy in left ventricular heart tissue identifies putative gene sets associated with cardiac pathology and early indicators of cardiac risk
Konstanze Tan, Darwin Tay, Wilson Lek Wen Tan, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Rachad Ghazal, Min Wang, Duan Liu, et al.
Circulation Research (2025) Vol. 136, Iss. 7, pp. 773-802
Closed Access
Taurine and Creatine Transporters as Potential Drug Targets in Cancer Therapy
Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3788-3788
Open Access | Times Cited: 12
Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation
Marion van Vugt, Chris Finan, Sandesh Chopade, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics
Arjan Sammani, Annette F. Baas, Folkert W. Asselbergs, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 921-921
Open Access | Times Cited: 24
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies
Johann Bauersachs, Rudolf A. de Boer, JoAnn Lindenfeld, et al.
European Heart Journal (2021) Vol. 43, Iss. 5, pp. 367-376
Open Access | Times Cited: 23
Identification of BMP10 as a Novel Gene Contributing to Dilated Cardiomyopathy
Jia-Ning Gu, Chenxi Yang, Yuanyuan Ding, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 242-242
Open Access | Times Cited: 10
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies
Alex Lipov, Sean J. Jurgens, Francesco Mazzarotto, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 11, pp. 1078-1094
Open Access | Times Cited: 10
Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease
William J. Young, Jeffrey Haessler, Jan Walter Benjamins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human
Julia E. Niskanen, Åsa Ohlsson, Ingrid Ljungvall, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Targeting ERBB2 and PIK3R1 as a therapeutic strategy for dilated cardiomyopathy: A single-cell sequencing and mendelian randomization analysis
Bin He, Li-Ping Quan, Chengban Li, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e25572-e25572
Open Access | Times Cited: 3
Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy
Sean L. Zheng, Albert Henry, Douglas Cannie, et al.
Nature Genetics (2024) Vol. 56, Iss. 12, pp. 2646-2658
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top